John G Park
Affiliation: Mayo Clinic
- Mediastinal lymphangioma: Mayo Clinic experience of 25 casesJohn G Park
Department of Pulmonary and Critical Care Medicine, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
Mayo Clin Proc 81:1197-203. 2006..To describe the clinical findings, treatment outcomes, disease recurrence rates, and survival of patients with pathologically confirmed mediastinal and cervicomediastinal lymphangioma...
- Updates on definition, consequences, and management of obstructive sleep apneaJohn G Park
Division of Pulmonary and Critical Care Medicine, Center for Sleep Medicine, Mayo Clinic, Rochester, MN 55905, USA
Mayo Clin Proc 86:549-54; quiz 554-5. 2011..This review focuses on updates in the areas of terminology and testing, complications of untreated OSA, perioperative considerations, treatment options, and new developments in this field...
- Pneumocystis carinii BCK1 functions in a mitogen-activated protein kinase cascade regulating fungal cell-wall assemblyCharles F Thomas
Thoracic Diseases Research Unit, Division of Pulmonary, Critical Care and Internal Medicine, Department of Medicine, 826 Stabile Building, Mayo Clinic and Foundation, Rochester, MN 55905, USA
FEBS Lett 548:59-68. 2003..Since glucan machinery is not present in mammals, a better understanding of this pathway in P. carinii might aid in the development of novel medications which interfere with the integrity of the Pneumocystis cell wall...
- Impact of zaleplon on continuous positive airway pressure therapy complianceJohn G Park
Center for Sleep Medicine, Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN
J Clin Sleep Med 9:439-44. 2013..To determine whether pretreatment with zaleplon immediately before CPAP titration improves 1-month CPAP adherence in subjects newly diagnosed with OSA...
- Obstructive sleep apnea-hypopnea syndromeEric J Olson
Mayo Clinic College of Medicine, Division of Pulmonary and Critical Care Medicine, Mayo Sleep Disorders Center, 200 1st Street SW, Rochester, MN 55905, USA
Prim Care 32:329-59. 2005..CPAP is the treatment of choice for most patients. Education, follow-up, and heated humidification may help bolster compliance. Lifestyle modifications, oral appliances, and upper surgeries are additional treatment options...
- Expression analysis of PCSTE3, a putative pheromone receptor from the lung pathogenic fungus Pneumocystis cariniiPawan K Vohra
Thoracic Diseases Research Unit, Division of Pulmonary, Critical Care and Internal Medicine, Department of Medicine, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
Biochem Biophys Res Commun 319:193-9. 2004..carinii life cycle stages and examined PCSTE3 expression by immunofluorescence microscopy and flow cytometry, and found PCSTE3 expression exclusively on a population of trophic forms. PCSTE3 receptor expression was not found on cysts...